Discover how biosimilars in Europe expand access, cut costs, and strengthen healthcare systems for a more sustainable future.

From plastic-eating plants to AI-guided therapies, iGEM 2025 reveals the innovations defining the future of synthetic biology ...

We spoke to five Australian companies in Vienna seeking collaborators and capital at the BIO Europe partnering conference.

Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...

The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research.

The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in ...

October 2025 saw a wave of M&As and biotech deals in various therapeutic fields, particularly for therapies addressing ...

Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.

The global biotech industry is booming, and by 2025 it will reach an estimated market worth of $729B. But while great innovation is driven by emerging biotechs, these companies often lack resources, ...